Details for Patent: 8,314,117
✉ Email this page to a colleague
Which drugs does patent 8,314,117 protect, and when does it expire?
Patent 8,314,117 protects NURTEC ODT and is included in one NDA.
This patent has forty-eight patent family members in thirty-four countries.
Summary for Patent: 8,314,117
Title: | CGRP receptor antagonists |
Abstract: | The disclosure generally relates to the novel compounds of formula I, including pharmaceutically acceptable salts, which are CGRP receptor antagonists. The disclosure also relates to pharmaceutical compositions and methods for using the compounds in the treatment of CGRP related disorders including migraine and other headaches, neurogenic vasodilation, neurogenic inflammation, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases such as asthma, and chronic obstructive pulmonary disease (COPD). ##STR00001## |
Inventor(s): | Luo; Guanglin (Madison, CT), Dubowchik; Gene M. (Middlefield, CT), Macor; John E. (Gullford, CT) |
Assignee: | Bristol-Myers Squibb Company (Princeton, NJ) |
Application Number: | 12/902,714 |
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Drugs Protected by US Patent 8,314,117
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | NURTEC ODT | rimegepant sulfate | TABLET, ORALLY DISINTEGRATING;ORAL | 212728-001 | Feb 27, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS | ⤷ Try a Trial | ||
Pfizer | NURTEC ODT | rimegepant sulfate | TABLET, ORALLY DISINTEGRATING;ORAL | 212728-001 | Feb 27, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | PREVENTIVE TREATMENT OF EPISODIC MIGRAINE IN ADULTS | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,314,117
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 078638 | ⤷ Try a Trial | |||
Argentina | 110069 | ⤷ Try a Trial | |||
Australia | 2010306954 | ⤷ Try a Trial | |||
Brazil | 112012008828 | ⤷ Try a Trial | |||
Canada | 2777518 | ⤷ Try a Trial | |||
Canada | 2968176 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |